BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 23763451)

  • 1. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.
    Chen Y; Wang M; Fang L
    Drug Deliv; 2013; 20(5):199-209. PubMed ID: 23763451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of therapeutic agents using dendrimers (US20140018435A1): a patent evaluation.
    Yang J; Hu J; He B; Cheng Y
    Expert Opin Ther Pat; 2015; 25(10):1209-14. PubMed ID: 26150049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of terpenes as skin penetration enhancers.
    Aqil M; Ahad A; Sultana Y; Ali A
    Drug Discov Today; 2007 Dec; 12(23-24):1061-7. PubMed ID: 18061886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
    Ita KB
    Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
    Amjadi M; Mostaghaci B; Sitti M
    Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
    Herman A; Herman AP
    J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical penetration enhancers: a patent review.
    Ahad A; Aqil M; Kohli K; Chaudhary H; Sultana Y; Mujeeb M; Talegaonkar S
    Expert Opin Ther Pat; 2009 Jul; 19(7):969-88. PubMed ID: 19552513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
    Kanikkannan N; Kandimalla K; Lamba SS; Singh M
    Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal systems as drug delivery vehicles for dermal and transdermal applications.
    Pierre MB; Dos Santos Miranda Costa I
    Arch Dermatol Res; 2011 Nov; 303(9):607-21. PubMed ID: 21805180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of transdermal penetration enhancers by high-throughput screening.
    Karande P; Jain A; Mitragotri S
    Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleodendrimers: a novel class of multicephalous heterolipids as chemical penetration enhancers for transdermal drug delivery.
    Kalhapure RS; Akamanchi KG
    Int J Pharm; 2013 Sep; 454(1):158-66. PubMed ID: 23871736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of peptide-based enhancers for transdermal delivery.
    Lopes LB; Carvalho VF; de Lemos DP
    Curr Pharm Des; 2015; 21(20):2814-22. PubMed ID: 25925116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous penetration enhancers: an overview.
    Thong HY; Zhai H; Maibach HI
    Skin Pharmacol Physiol; 2007; 20(6):272-82. PubMed ID: 17717423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers.
    Obata Y; Utsumi S; Watanabe H; Suda M; Tokudome Y; Otsuka M; Takayama K
    Int J Pharm; 2010 Apr; 389(1-2):18-23. PubMed ID: 20079819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics.
    Torin Huzil J; Sivaloganathan S; Kohandel M; Foldvari M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(5):449-462. PubMed ID: 21595050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeation enhancers in transdermal drug delivery: benefits and limitations.
    Kováčik A; Kopečná M; Vávrová K
    Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.